Webinar | September 22, 2022

Development And Regulatory Strategy For US And China

Source: Novotech

This webinar discusses the expansion of international market for Ensartini and RNAi Therapeutics in oncology, from skin cancers to liver cancers. Additionally, it aims to understand the evolving U.S. regulatory requirements for diversity in clinical cancer trials.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Novotech